ID

44719

Beskrivning

see http://clinicaltrials.gov/ct2/show/record/NCT00617669 Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Länk

http://clinicaltrials.gov/ct2/show/record/NCT00617669

Nyckelord

  1. 2011-11-15 2011-11-15 -
  2. 2014-03-23 2014-03-23 - Martin Dugas
  3. 2014-08-10 2014-08-10 - Martin Dugas
  4. 2021-04-13 2021-04-13 - Dr. rer. medic Philipp Neuhaus
  5. 2021-09-20 2021-09-20 -
  6. 2021-09-28 2021-09-28 - Sarah Riepenhausen
Rättsinnehavare

AstraZeneca

Uppladdad den

28 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility DRKS00005404 NCT00617669 Prostate Cancer

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Beskrivning

Age

Datatyp

integer

Måttenheter
  • years
Alias
UMLS CUI-1
C0001779
years
male
Beskrivning

Gender Male

Datatyp

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
Beskrivning

Prostate Cancer with bone metastasis

Datatyp

boolean

Alias
UMLS CUI-1
C0600139
UMLS CUI-2
C0153690
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Beskrivning

PSA increase

Datatyp

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Beskrivning

Castration

Datatyp

boolean

Alias
UMLS CUI-1
C0007347
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Beskrivning

Previous chemotherapy

Datatyp

boolean

Alias
UMLS CUI-1
C0205156
UMLS CUI-2
C0392920
Suffering from heart failure or had a myocardial infarction within last 6 months
Beskrivning

Heart disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0155626
A history of epilepsy or seizures
Beskrivning

Epilepsy, seizures

Datatyp

boolean

Alias
UMLS CUI-1
C0014544
UMLS CUI-2
C0036572

Similar models

Eligibility NCT00617669

  1. StudyEvent: Eligibility
    1. Eligibility NCT00617669
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
integer
C0001779 (UMLS CUI-1)
Gender Male
Item
male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer with bone metastasis
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastasis)
boolean
C0600139 (UMLS CUI-1)
C0153690 (UMLS CUI-2)
PSA increase
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C0205156 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018801 (UMLS CUI [1,1])
C0155626 (UMLS CUI [1,2])
Epilepsy, seizures
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)
C0036572 (UMLS CUI-2)

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial